Home / Stocks / ABBV

ABBV insider trading

AbbVie Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-18Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Sold32,710$250.00$8.2M
2026-03-06Purdue David Ryan
SVP, Controller
Sold5,230$233.56$1.2M
2026-03-03Siatis Perry C
EVP, GC AND SECRETARY
Sold16,068$234.25$3.8M
2026-02-27Siatis Perry C
EVP, GC AND SECRETARY
Sold22,381$230.00$5.1M
2025-08-14SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
Sold42,370$198.42$8.4M
2025-08-07Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Sold10,061$198.59$2.0M
2025-04-02Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
Sold58,832$210.08$12.4M
2025-03-18Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
Sold17,644$212.34$3.7M
2025-03-04GONZALEZ RICHARD A
Director
Sold98,628$205.45$20.3M
2025-03-04Siatis Perry C
EVP, GC AND SECRETARY
Sold24,819$209.07$5.2M
2025-03-04RICHMOND TIMOTHY J.
EVP, CHIEF HR OFFICER
Sold20,650$210.42$4.3M
2025-02-28Buckbee Kevin K
SVP, CONTROLLER
Sold16,260$203.41$3.3M
2025-02-28RICHMOND TIMOTHY J.
EVP, CHIEF HR OFFICER
Sold13,073$202.92$2.7M

See ABBV on the chart

Every insider buy and sell for ABBV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.